Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NorthShore Bio
AddedFeb 16, 2024
UpdatedJun 18, 2026
NorthShore Bio

NorthShore Bio

Series A

NorthShore Bio: Innovating a silicon-chip Molecular Detection Platform technology.

HQ
Camas, WA, US
Founded
2009
Overview
Compare
Fundraising
Employees

NorthShore Bio is dedicated to innovating a silicon-chip Molecular Detection Platform technology. Their core mission is to advance molecular detection capabilities through cutting-edge silicon-chip technology. They focus on providing platform technology solutions that cater to various market needs in the biotechnology and healthcare sectors.

NorthShore Bio has achieved significant milestones in developing their proprietary silicon-chip technology, which promises enhanced accuracy and efficiency in molecular detection. Their impact is notable in the biotech industry, contributing to advancements in diagnostic and research applications.

NorthShore Bio - Similar Companies

Ontera logo

Ontera

ontera.bio

Caspr logo

Caspr

BioCeryx logo

BioCeryx

NuProbe logo

NuProbe

nuprobe.com

NanoDetection Technology logo

NanoDetection Technology

Torus Biosystems logo

Torus Biosystems

Nanopath logo

Nanopath

nanopathdx.com

Enumera Molecular logo

Enumera Molecular

Newomics logo

Newomics

newomics.com

Bar Harbor BioTechnology logo

Bar Harbor BioTechnology

NanoMosaic logo

NanoMosaic

InSilixa logo

InSilixa

Nortis logo

Nortis

nortisbio.com

NexGen Arrays logo

NexGen Arrays

Diagnostic Biochips logo

Diagnostic Biochips

NorthShore Bio - Quick Facts

Who are NorthShore Bio's competitors?

Companies similar to NorthShore Bio include Ontera, Caspr, BioCeryx and NuProbe.

When was NorthShore Bio founded?

NorthShore Bio was founded in 2009.

Where is NorthShore Bio's headquarters located?

NorthShore Bio's headquarters is located in Camas, WA, US.

How much has NorthShore Bio raised to-date?

As of Nov 1, 2015, NorthShore Bio has raised a total of $1.5M (USD).

How many employees does NorthShore Bio have?

NorthShore Bio has 30 employees as of Feb 4, 2024.

NorthShore Bio - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Molecular Detection
Tags
  • Biotech
  • Data
  • Technology
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software